Organic small molecules with novel mechanisms of action (nMoAs) are needed to help address today's most challenging biomedical problems. In particular, potential disease-related molecular targets ...
Matthew Addicoat receives funding from EPSRC and the Royal Society. The universe is flooded with billions of chemicals, each a tiny pinprick of potential. And we’ve only identified 1% of them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback